In this issue:
Eculizumab improves survival in paroxysmal nocturnal haemoglobinuria
Aspirin/heparin did not prevent miscarriage in two studies
Parental history for assessing VTE risk
Romiplostim improves outcomes in immune thrombocytopenia
Risks of arterial/venous thrombosis in essential thrombocythaemia
High hepcidin during deferasirox in iron-overloaded patients with MDS
Anticoagulation self-testing/management appears to improve outcomes
XXIII Congress of the ISTH
• MAGELLAN: rivaroxaban
vs. enoxaparin for VTE prevention
• Pharmacokinetics and safety of N9-GP and rFVIIIFc; two human studies
Please login below to download this issue (PDF)